Cwm, LLC Prothena Corp Public LTD CO Transaction History
Cwm, LLC
- $21.2 Billion
- Q2 2024
A detailed history of Cwm, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Cwm, LLC holds 798 shares of PRTA stock, worth $16,231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
798
Previous 1,095
27.12%
Holding current value
$16,231
Previous $27,000
40.74%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding PRTA
# of Institutions
182Shares Held
42.7MCall Options Held
77.7KPut Options Held
92.7K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$236 Million8.45% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.24MShares$86.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$78.5 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.64MShares$74 Million0.01% of portfolio
-
State Street Corp Boston, MA1.93MShares$39.3 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $954M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...